Tevogen (TVGN): See Remarks sold ~$3.3K
Neal Flomenberg, See Remarks at Tevogen, sold ~$3.3K of Tevogen shares.
- ~$3.3K
- Approx. value · 452 sh @ $7.26
- 77K
- Holds after · shares reported
- Traded
- Mar 11, 2026
- Filed
- Mar 17, 2026
What stands out in this filing
- The sale was 0.6% of the shares this insider held before it; the filing reports 77,441 shares afterwards.
- 452 shares at an average of $7.26 each, as reported on the form.
- Footnote references tax withholding.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 19, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On February 19, 2026, Tevogen Bio Holdings Inc. (the “Company”) held a special meeting of its stockholders (the “Special Meeting”).”
- Mar 3, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year (and 1 more item)
- Mar 10, 2026InsiderOfficer sold ~$147 of TVGN shares in the open market
- Mar 11, 2026 · this disclosureInsiderOfficer sold ~$3.3K of TVGN shares in the open market
What came next
- Mar 13, 2026InsiderOfficer sold ~$3.2K of TVGN shares in the open market
- Apr 16, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On April 16, 2026, Tevogen Bio Holdings Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company no longer meets Nasdaq’s $50 million minimum market value for listed securities requirement pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”) for continued listing on the Nasdaq…”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Tevogen
For Tevogen, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TVGN page.
Other recent filings by Neal Flomenberg, See Remarks
- SEC Form 4 at Tevogen (TVGN)Mar 17, 2026
- SEC Form 4 at Tevogen (TVGN)Mar 17, 2026
- SEC Form 4 at Tevogen (TVGN)Mar 15, 2025
- SEC Form 4 at Tevogen (TVGN)Mar 12, 2025
- SEC Form 4 at Tevogen (TVGN)Mar 12, 2025
The full history of Neal Flomenberg, See Remarks is on the profile page.
How this filing works
Explore the data
Common questions
Which Tevogen (TVGN) insider traded, and how much?
Neal Flomenberg, See Remarks at Tevogen, sold ~$3.3K of Tevogen shares. 452 shares at $7.26.
When did it happen, and when was it made public?
Traded: Mar 11, 2026. Filed: Mar 17, 2026. That is 6 days between the two dates.
What stands out in this filing?
The sale was 0.6% of the shares this insider held before it; the filing reports 77,441 shares afterwards. 452 shares at an average of $7.26 each, as reported on the form. Footnote references tax withholding.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Tevogen recently?
For Tevogen, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the TVGN page.
Does this mean TVGN stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Tevogen
- SEC Schedule 13DNov 4, 2026
- SEC Form 4Mar 17, 2026
- SEC Form 4Mar 17, 2026
- SEC Form 4Jun 9, 2025
- SEC Form 4Mar 15, 2025
- SEC Form 4Mar 12, 2025
Everything OQRO holds on this company is on its TVGN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
